Pharmacokinetics, biological activities and health benefits of hydroxycinnamic acids and their metabolites
Food and Drug Administration (FDA) approved Eli Lilly and Companys Zepbound (tirzepatide), an obesity medication, for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity
FDA prescribing information for some GLP-1 receptor agonists advises considering discontinuation for sustained increases in resting heart rate
Unopened vials and pens should remain refrigerated from the moment they leave the manufacturing facility until you are ready to use them
Nausea, fatigue, and appetite suppression make exercise challenging
James | Journal: Journal of Medical Internet Research | Publication Date: January 9, 2026 | Volume/Issue: Volume 28, Article e78391 | DOI: 10.2196/78391 | Study Design: Mixed methods analysis combining qualitative thematic analysis with quantitative rating data from 60 publicly available, anonymous user reviews posted on Drugs.com between February and June 2023.